Clinical Significance of the Stromatic Component in Ovarian Cancer: Quantity Over Quality in Outcome Prediction
E. Lou, V. Clemente, M. Grube, A. Svedbom, A. C. Nelson, F. Blome, A. Staebler, S. Kommoss, M. Bazzaro
This study shows that higher tumor-stroma proportion (TSP) in ovarian cancer is linked to worse patient outcomes, including shorter progression-free and overall survival, and increased chemoresistance.
bioRxiv · Jun 27, 2023 · PreprintPathology